← FDA DRUG APPROVALS

FDA ANDA · ANDA211968

SODIUM CHLORIDE

Sponsor: NEPHRON

APPLICATION
ANDA211968
TYPE
ANDA
ORIGINAL APPROVAL
2020-04-23
LATEST ACTION
2020-04-23
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERPrescription
SODIUM CHLORIDE 450MG/50ML (9MG/ML) · SOLUTION · INJECTION
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERPrescription
SODIUM CHLORIDE 900MG/100ML · SOLUTION · INJECTION

Approval history

2020-04-23UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →